| Dr Sylvia Wang, MD | |
|
414 Uluniu St, Kailua, HI 96734-2517 | |
| (808) 261-8345 | |
| (808) 262-5239 |
| Full Name | Dr Sylvia Wang |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 29 Years |
| Location | 414 Uluniu St, Kailua, Hawaii |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043254113 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 10946 (Hawaii) | Secondary |
| 207R00000X | Internal Medicine | MD10946 (Hawaii) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventist Health Castle | Kailua, HI | Hospital |
| The Queens Medical Center | Honolulu, HI | Hospital |
| Kapiolani Medical Center For Women & Children | Honolulu, HI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Clinic Inc | 8921998808 | 6 |
News Archive
A new study from the Ottawa Hospital Research Institute (OHRI) and the University of Ottawa suggests that stem cells intentionally break their own DNA as a way of regulating tissue development. The study, published in Proceedings of the National Academy of Science (PNAS), could dramatically change how researchers think about tissue development, stem cells and cancer.
Research shows that spending just 20 minutes in nature can promote health and well-being. Although the assumption may be that living in rural areas provides ample opportunities for recreation in nature, many rural, low-income mothers, who rely on outdoor activities to promote health and well-being for themselves and their families, face obstacles in accessing publicly available outdoor recreation resources.
Valeant Pharmaceuticals International, Inc. today announced that that its wholly owned subsidiary, Valeant Pharmaceuticals North America LLC, received notice that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Jublia® (efinaconazole 10% topical solution), the first topical triazole approved for the treatment of onychomycosis of the toenails.
"The U.S. Food and Drug Administration on Monday approved Johnson & Johnson's drug to treat a form of resistant tuberculosis that is uncommon in the U.S. but growing globally," the Wall Street Journal reports.
Florida Doctors Insurance Company (FLDIC) announced today it has successfully completed a merger and acquisition of Physicians Preferred Insurance Company (PPIC), making FLDIC the fourth largest admitted writer of physicians and surgeons medical professional liability insurance in Florida.
› Verified 2 days ago
| Entity Name | Medical Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144234402 PECOS PAC ID: 8921998808 Enrollment ID: O20040316000598 |
News Archive
A new study from the Ottawa Hospital Research Institute (OHRI) and the University of Ottawa suggests that stem cells intentionally break their own DNA as a way of regulating tissue development. The study, published in Proceedings of the National Academy of Science (PNAS), could dramatically change how researchers think about tissue development, stem cells and cancer.
Research shows that spending just 20 minutes in nature can promote health and well-being. Although the assumption may be that living in rural areas provides ample opportunities for recreation in nature, many rural, low-income mothers, who rely on outdoor activities to promote health and well-being for themselves and their families, face obstacles in accessing publicly available outdoor recreation resources.
Valeant Pharmaceuticals International, Inc. today announced that that its wholly owned subsidiary, Valeant Pharmaceuticals North America LLC, received notice that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Jublia® (efinaconazole 10% topical solution), the first topical triazole approved for the treatment of onychomycosis of the toenails.
"The U.S. Food and Drug Administration on Monday approved Johnson & Johnson's drug to treat a form of resistant tuberculosis that is uncommon in the U.S. but growing globally," the Wall Street Journal reports.
Florida Doctors Insurance Company (FLDIC) announced today it has successfully completed a merger and acquisition of Physicians Preferred Insurance Company (PPIC), making FLDIC the fourth largest admitted writer of physicians and surgeons medical professional liability insurance in Florida.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sylvia Wang, MD 414 Uluniu St, Medical Clinic Inc, Kailua, HI 96734-2517 Ph: (808) 261-8345 | Dr Sylvia Wang, MD 414 Uluniu St, Kailua, HI 96734-2517 Ph: (808) 261-8345 |
News Archive
A new study from the Ottawa Hospital Research Institute (OHRI) and the University of Ottawa suggests that stem cells intentionally break their own DNA as a way of regulating tissue development. The study, published in Proceedings of the National Academy of Science (PNAS), could dramatically change how researchers think about tissue development, stem cells and cancer.
Research shows that spending just 20 minutes in nature can promote health and well-being. Although the assumption may be that living in rural areas provides ample opportunities for recreation in nature, many rural, low-income mothers, who rely on outdoor activities to promote health and well-being for themselves and their families, face obstacles in accessing publicly available outdoor recreation resources.
Valeant Pharmaceuticals International, Inc. today announced that that its wholly owned subsidiary, Valeant Pharmaceuticals North America LLC, received notice that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Jublia® (efinaconazole 10% topical solution), the first topical triazole approved for the treatment of onychomycosis of the toenails.
"The U.S. Food and Drug Administration on Monday approved Johnson & Johnson's drug to treat a form of resistant tuberculosis that is uncommon in the U.S. but growing globally," the Wall Street Journal reports.
Florida Doctors Insurance Company (FLDIC) announced today it has successfully completed a merger and acquisition of Physicians Preferred Insurance Company (PPIC), making FLDIC the fourth largest admitted writer of physicians and surgeons medical professional liability insurance in Florida.
› Verified 2 days ago
Mr. Howard I Keller, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 30 Aulike St, Suite 601, Kailua, HI 96734 Phone: 808-262-6951 Fax: 808-261-7856 | |
Dr. Jamalah Adeeba Munir, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 642 Ulukahiki St, Kailua, HI 96734 Phone: 808-263-5174 | |
Naoky C Tsai, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 642 Ulukahiki St, Ste 103, Kailua, HI 96734 Phone: 808-263-5174 Fax: 808-266-3614 | |
Dr. Joseph A Palma, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 638 Papalani St, Kailua, HI 96734 Phone: 808-262-9887 Fax: 808-262-7013 | |
Ramy A Badawi, MD, MBBS Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 640 Ulukahiki St, Kailua, HI 96734 Phone: 808-793-7747 Fax: 808-625-4808 | |
Dr. Helen Ing, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 642 Ulukahiki St, #211, Kailua, HI 96734 Phone: 808-261-0765 Fax: 808-262-5636 |